Madrigal Pharmaceuticals, Inc. (MDGL)
435.01
-1.86
(-0.43%)
USD |
NASDAQ |
Feb 20, 16:00
435.20
+0.19
(+0.04%)
After-Hours: 20:00
Madrigal Pharmaceuticals SG&A Expense (Quarterly) : 0.00 for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pfizer Inc. | 4.162B |
| Eli Lilly & Co. | 3.132B |
| Insmed, Inc. | 212.48M |
| Johnson & Johnson | 6.753B |
| Crinetics Pharmaceuticals, Inc. | 52.26M |